ArticleCureus2023

Treatment Outcomes of Dolutegravir- Versus Efavirenz-Based Highly Active Antiretroviral Therapy Regimens Among Treatment-Naive People Living With HIV.

Prarthana R Mahale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.